
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
PEMD-96-1 FDA Drug Approval: Review Time Has Decreased in Recent Years
The U.S. Food and Drug Administration's drug approval process has undergone significant changes, leading to a reduction in the time it takes to review new medications. This report from the United States Accounting Office (GAO) investigates the trends in FDA drug approval review times over recent years. It examines the factors contributing to these changes and provides data on the efficiency of the regulatory process. The analysis aims to inform stakeholders about the evolving landscape of pharmaceutical regulation.
This report is a factual account from the United States Accounting Office (GAO), a non-partisan agency that audits federal spending. Its findings are based on data and analysis of the FDA's drug approval process. The report is likely to be of interest to policymakers, pharmaceutical industry professionals, and researchers focused on regulatory science and public health. Its objective tone and data-driven approach suggest it serves as an informational resource rather than a piece of persuasive advocacy.
Page Count:
46
Publication Date:
2018-04-09
Publisher:
CreateSpace Independent Publishing Platform
ISBN-10:
1987516001
ISBN-13:
9781987516005
No comments yet. Be the first to share your thoughts!